Activation of NRF2/FPN1 Pathway Attenuates Myocardial Ischemia-reperfusion Injury in Diabetic Rats by Regulating Iron Homeostasis and Ferroptosis

Overview

Journal Cell Stress Chaperones

Publisher Elsevier

Specialty Cell Biology

Date 2022 Feb 6

PMID 35124772

Authors

Hao Tian

Yonghong Xiong

Yi Zhang

Yan Leng

Jie Tao

Lu Li

Zhen Qiu

Zhongyuan Xia

Affiliations

Soon will be listed here.

Abstract

In patients with ischemic heart disease, myocardial ischemia-reperfusion injury (IRI) can aggravate their condition even worse, and diabetes increases their risk of myocardial IRI. Pathological pathways of common diseases and surgical operations like diabetes, obesity, coronary artery angioplasty, and heart transplantation entail disorders of iron metabolism. Ferroportin1 (FPN1) is the only mammalian protein associated with iron release and thus plays a vital role in iron homeostasis, while nuclear factor E2-related factor 2 (NRF2) controls the transcription of FPN1. Since the NRF2/FPN1 pathway may play a favorable role in the therapy of diabetic myocardial IRI, this work investigated the possible mechanism. In this study, we investigated the effects of ferroptosis in STZ-induced diabetic rats following myocardial IRI in vivo, and its alteration in glucose and hypoxia/reoxygenation-induced cardiomyocytes injury in vitro. Rats and H9c2 cardiomyocytes were randomly divided into 6 groups and treated with sulforaphane and erastin besides the establishment of diabetic myocardial IRI and hyperglycemic hypoxia-reoxygenation models. Cardiac functional and structural damage were detected by Evans blue/TTC double staining, echocardiography, HE staining, and serological indices. CCK-8 assay and ROS production were used to measure cardiomyocyte viability and oxidative stress level. Additionally, the changes in cell supernatant levels of Fe, SOD, MDA, and mRNA and protein expression of ferroptosis marker proteins confirmed the beneficial effects of the NRF2/FPN1 pathway on diabetic myocardial IRI related to iron metabolism and ferroptosis. Overall, these findings suggest that iron homeostasis-related ferroptosis plays an important role in aggravating myocardial IRI in diabetic rats, and NRF2/FPN1 pathway-mediated iron homeostasis and ferroptosis might be a promising therapeutic target against myocardial IRI in diabetes.

Citing Articles

Novel impact of metal ion-induced cell death on diabetic cardiomyopathy pathogenesis and therapy.

Jiang J, Hu S, Hu K, Xiao L, Lin J, Chen Y Apoptosis. 2025; .

PMID: 40042744 DOI: 10.1007/s10495-025-02090-4.

Targeted temperature management alleviates post-resuscitation myocardial dysfunction by inhibiting ferroptosis.

Zhang Y, Du W, Kong T, Hua T, Ma H, Hu Y Cell Death Discov. 2025; 11(1):71.

PMID: 39984437 PMC: 11845627. DOI: 10.1038/s41420-025-02356-5.

Genome-wide KAS-Seq mapping of leukocytes in ischemia-reperfusion model reveals IL7R as a potential therapeutic target for ischemia-reperfusion injury.

Zhang L, Duolikun M, Chen H, Wang Z, Li X, Xiao H Sci Rep. 2025; 15(1):6165.

PMID: 39979392 PMC: 11842730. DOI: 10.1038/s41598-025-90457-7.

USP9X suppresses ferroptosis in diabetic kidney disease by deubiquitinating Nrf2 .

Shao N, Cai K, Hong Y, Wu L, Luo Q Ren Fail. 2025; 47(1):2458761.

PMID: 39967230 PMC: 11841168. DOI: 10.1080/0886022X.2025.2458761.

Mechanism of mTOR/RILP-regulated autophagic flux in increased susceptibility to myocardial ischemia-reperfusion in diabetic mice.

Zhao J, Shi W, Zheng Y, Wang J, Yuan M, Anwar Y Front Pharmacol. 2025; 15:1506401.

PMID: 39958873 PMC: 11825452. DOI: 10.3389/fphar.2024.1506401.

References

Crisafulli A, Pagliaro P, Roberto S, Cugusi L, Mercuro G, Lazou A . Diabetic Cardiomyopathy and Ischemic Heart Disease: Prevention and Therapy by Exercise and Conditioning. Int J Mol Sci. 2020; 21(8). PMC: 7215312. DOI: 10.3390/ijms21082896. View

Ichihara S . The pathological roles of environmental and redox stresses in cardiovascular diseases. Environ Health Prev Med. 2013; 18(3):177-84. PMC: 3650174. DOI: 10.1007/s12199-012-0326-2. View

Piao C, Gao S, Lee G, Kim D, Park B, Chae S . Sulforaphane protects ischemic injury of hearts through antioxidant pathway and mitochondrial K(ATP) channels. Pharmacol Res. 2009; 61(4):342-8. DOI: 10.1016/j.phrs.2009.11.009. View

Galluzzi L, Vitale I, Abrams J, Alnemri E, Baehrecke E, Blagosklonny M . Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 2011; 19(1):107-20. PMC: 3252826. DOI: 10.1038/cdd.2011.96. View

Li W, Li W, Wang Y, Leng Y, Xia Z . Inhibition of DNMT-1 alleviates ferroptosis through NCOA4 mediated ferritinophagy during diabetes myocardial ischemia/reperfusion injury. Cell Death Discov. 2021; 7(1):267. PMC: 8481302. DOI: 10.1038/s41420-021-00656-0. View

Marro S, Chiabrando D, Messana E, Stolte J, Turco E, Tolosano E . Heme controls ferroportin1 (FPN1) transcription involving Bach1, Nrf2 and a MARE/ARE sequence motif at position -7007 of the FPN1 promoter. Haematologica. 2010; 95(8):1261-8. PMC: 2913073. DOI: 10.3324/haematol.2009.020123. View

Wang C, Zhu L, Yuan W, Sun L, Xia Z, Zhang Z . Diabetes aggravates myocardial ischaemia reperfusion injury via activating Nox2-related programmed cell death in an AMPK-dependent manner. J Cell Mol Med. 2020; 24(12):6670-6679. PMC: 7299688. DOI: 10.1111/jcmm.15318. View

Li W, Li W, Leng Y, Xiong Y, Xia Z . Ferroptosis Is Involved in Diabetes Myocardial Ischemia/Reperfusion Injury Through Endoplasmic Reticulum Stress. DNA Cell Biol. 2019; 39(2):210-225. DOI: 10.1089/dna.2019.5097. View

Kagan V, Mao G, Qu F, Friedmann Angeli J, Doll S, St Croix C . Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 2016; 13(1):81-90. PMC: 5506843. DOI: 10.1038/nchembio.2238. View

10.

Xu G, Zhao X, Fu J, Wang X . Resveratrol increase myocardial Nrf2 expression in type 2 diabetic rats and alleviate myocardial ischemia/reperfusion injury (MIRI). Ann Palliat Med. 2019; 8(5):565-575. DOI: 10.21037/apm.2019.11.25. View

11.

Fang X, Wang H, Han D, Xie E, Yang X, Wei J . Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci U S A. 2019; 116(7):2672-2680. PMC: 6377499. DOI: 10.1073/pnas.1821022116. View

12.

Liu Z, Han K, Huo X, Yan B, Gao M, Lv X . Nrf2 knockout dysregulates iron metabolism and increases the hemolysis through ROS in aging mice. Life Sci. 2020; 255:117838. DOI: 10.1016/j.lfs.2020.117838. View

13.

Harada N, Kanayama M, Maruyama A, Yoshida A, Tazumi K, Hosoya T . Nrf2 regulates ferroportin 1-mediated iron efflux and counteracts lipopolysaccharide-induced ferroportin 1 mRNA suppression in macrophages. Arch Biochem Biophys. 2011; 508(1):101-9. DOI: 10.1016/j.abb.2011.02.001. View

14.

Zhou X, Ru X, Xiao C, Pan J, Lou Y, Tang L . Sestrin2 is involved in the Nrf2-regulated antioxidative signaling pathway in luteolin-induced prevention of the diabetic rat heart from ischemia/reperfusion injury. Food Funct. 2021; 12(8):3562-3571. DOI: 10.1039/d0fo02942d. View

15.

Wang W, Lu Q, Wang X, Wang B, Wang J, Gong H . Ulinastatin attenuates diabetes-induced cardiac dysfunction by the inhibition of inflammation and apoptosis. Exp Ther Med. 2017; 14(3):2497-2504. PMC: 5609313. DOI: 10.3892/etm.2017.4824. View

16.

Gozzelino R, Arosio P . Iron Homeostasis in Health and Disease. Int J Mol Sci. 2016; 17(1). PMC: 4730371. DOI: 10.3390/ijms17010130. View

17.

Xiao C, Xia M, Wang J, Zhou X, Lou Y, Tang L . Luteolin Attenuates Cardiac Ischemia/Reperfusion Injury in Diabetic Rats by Modulating Nrf2 Antioxidative Function. Oxid Med Cell Longev. 2019; 2019:2719252. PMC: 6476158. DOI: 10.1155/2019/2719252. View

18.

Doll S, Porto Freitas F, Shah R, Aldrovandi M, Costa Da Silva M, Ingold I . FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019; 575(7784):693-698. DOI: 10.1038/s41586-019-1707-0. View

19.

Yuan H, Li X, Zhang X, Kang R, Tang D . Identification of ACSL4 as a biomarker and contributor of ferroptosis. Biochem Biophys Res Commun. 2016; 478(3):1338-43. DOI: 10.1016/j.bbrc.2016.08.124. View

20.

Qi X, Zhang Y, Guo H, Hai Y, Luo Y, Yue T . Mechanism and intervention measures of iron side effects on the intestine. Crit Rev Food Sci Nutr. 2019; 60(12):2113-2125. DOI: 10.1080/10408398.2019.1630599. View